Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Blend Uniformity Testing

Posted on By

SOP for Blend Uniformity Testing

Procedure for Blend Uniformity Analysis

1) Purpose

The purpose of this SOP is to outline the procedure for performing blend uniformity testing to ensure the homogeneity of pharmaceutical blends prior to tablet or capsule production.

2) Scope

This SOP applies to all pharmaceutical blends prepared for tablet or capsule production within the manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting blend uniformity testing and ensuring compliance with this SOP.
Production Department: Responsible for providing samples of the blend for testing and adhering to blend uniformity standards.

4) Procedure

4.1 Sampling:
    4.1.1 Collect blend samples at various points within the blender according to the sampling plan.
    4.1.2 Ensure samples are representative of the entire blend.
4.2 Sample Preparation:
    4.2.1 Weigh a specific amount of each sample as per the analytical method.
    4.2.2 Dissolve or extract the sample in a suitable solvent if required.
4.3 Analysis:
    4.3.1 Perform the appropriate analytical method (e.g., HPLC, UV spectrophotometry) to determine the active ingredient concentration in each sample.
    4.3.2 Record the results for each sample.
4.4 Calculation:
    4.4.1 Calculate the mean concentration of the active ingredient from all samples.
    4.4.2 Determine the relative standard deviation (RSD) to assess uniformity.
4.5 Acceptance Criteria:
    4.5.1 The blend is

considered uniform if the RSD is within the specified limits (< 5% RSD typically).
See also  SOP for Nasal Spray Pump Performance Testing
4.6 Documentation:
    4.6.1 Document all results and calculations in the Blend Uniformity Test Record.
    4.6.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

HPLC: High-Performance Liquid Chromatography
RSD: Relative Standard Deviation
UV: Ultraviolet

6) Documents, if any

Blend Uniformity Test Record
Analytical Method SOP
Sampling Plan Document

7) Reference, if any

21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Complaint Handling in Ointment Formulation
Next Post: SOP for Record-Keeping for Taste and Odor Evaluations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version